Arvinas announces research collaboration and license agreement with Pfizer Inc. for the discovery and development of protein degradation drug candidates. Arvinas LLC, a private biotechnology company focused on creating a new class of drugs based on protein degradation, announced a research collaboration and license agreement with Pfizer Inc. for the discovery and development of drug candidates…